11 August 2023 | Bangkok Dusit Medical Services Public Company Limited |
MANAGEMENT DISCUSSION AND ANALYSIS
Executive Summary
2Q23 & 6M23 Performance
2Q23 | 6M23 | ||||||
THB | % Chg | THB | % Chg | ||||
mm | ( | YoY) | mm | ( | YoY) | ||
Operating Income | 24,372 | 11% | 48,685 | 8% | |||
EBITDA | 5,510 | 8% | 11,497 | 2% | |||
Net Profit | 3,063 | 15% | 6,533 | 7% | |||
Remark: YoY means changes comparing to 2Q22 and 6M22
2Q23 Performance
Bangkok Dusit Medical Services Public Company Limited ("The Company") and subsidiaries reported consolidated operating income for the second quarter of 2023 ("2Q23") of Baht 24,372 million, an increase of 11% from 2Q22. The growth was attributable to an increase in revenue from hospital operations of 10% YoY which was driven by growth of Center of Excellence (COE) together with international patient revenues growth of 22% YoY and Thai patient revenues growth of 7% YoY.
The Company and its subsidiaries reported EBITDA of Baht 5,510 million, increased by 8% YoY and net profit of Baht 3,063 million, increased by 15% YoY.
6M23 Performance
For six-month period ended 30 June 2023 ("6M23"), the consolidated operating income were Baht 48,685 million, increased by 8% YoY. The growth was attributable to an increase in revenue from hospital operations of 7% YoY driven mainly from strong growth of 30% YoY from international patient revenues. However, Thai patient revenues growth was flat YoY due to impact from decline in COVID-19
patient revenues, despite Thai-NonCOVID-19 revenues increased 25% YoY in 6M23.
The Company and its subsidiaries reported EBITDA of Baht 11,497 million, increased by 2% YoY and net profit of 6,533 million, increased by 7% YoY
Major Development in 2Q23
New network hospital
Bangkok Hospital Pluak Daeng, a 58th hospital under BDMS network, had grand opening in June 2023 with 1st phase of 59 beds (from 180 structured beds). It is located at Pluak Daeng, Rayong province, area of Eastern Economic Corridor ("EEC"). It offers tertiary care services such as Internal Medicine, Pediatrics, Surgery, Trauma, Occupational Health, Brain, Radiology, Orthopedic.
Bangkok Hospital Pluak Daeng has collaboration with Bangkok Hospital Rayong, a Center of Excellence in BDMS networks. This helps increase medical treatment capability and refer patients in Eastern part of Thailand given strong demand from increasing population in EEC area.
2Q23 Consolidated Financial Summary
Operating Income
(THB mm) | 2Q23 | 2Q22 | YoY | QoQ |
Hospital operations | 23,141 | 20,976 | 10% | 0% |
Sales of goods | 941 | 796 | 18% | 2% |
Other income | 291 | 209 | 39% | (4)% |
Total Operating | ||||
Income | 24,372 | 21,981 | 11% | 0% |
Remark: QoQ means changes comparing to 1Q23.
1
Operating Income Comparing to 2Q23 (YoY)
In 2Q23, total operating income was Baht 24,372 million, an increase of Baht 2,391 million or 11% YoY, primarily due to
-
Revenues from hospital operations were Baht 23,141 million, an increase of Baht 2,164 million or 10% YoY mainly from growth of COE of 13% YoY as a result of returning from international and Thai patients for medical treatment. Overall international patient revenues increased by 22% YoY from a recovery of fly-in patients mainly from China 61% YoY, Middle East 33% YoY and CLMV (Cambodia, Laos, Myanmar and Vietnam) 30% YoY. Moreover, Thai patient revenues increased by 7% YoY in 2Q23, despite COVID-19 related revenues decreased sharply from 2Q22, due mainly to recovery of Thai patients together with epidemic i.e. dengue fever, Norovirus (diarrhea).
Revenue proportion between Thai and international patients changed from 76%:24% in 2Q22 to 74%:26% in 2Q23.
Overall, revenues from hospital operations in 2Q23 showed good growth in both Bangkok & Vicinity and outside Bangkok at 6% and 16% YoY, respectively. Hospital operations outside Bangkok provided higher growth due to medical tourist rebound in Pattaya and Phuket together with local epidemic.
Outpatient revenues growth was 7% YoY while inpatient revenues showed better growth of 13% YoY from COE, especially to international patients.
Although admission of international patients was positive in 2Q23 but there was a sharp decline in admission of COVID-19 patients, when compared with 2Q22, resulting in overall occupancy rate to decrease from 69% in 2Q22 to 65% in 2Q23.
Revenues from hospital | Chg. | % of | ||||
operations in 2Q23 | (YoY) | revenues | ||||
Revenues growth from | ||||||
hospital operations | 10% | |||||
Breakdown by nationality | ||||||
Thai | 7% | 74% | ||||
Thai- Non COVID | 28% | |||||
International | 22% | 26% | ||||
Breakdown by location | ||||||
Bangkok & Vicinity | 6% | 56% | ||||
Outside Bangkok | 16% | 44% | ||||
Breakdown by type of patients | ||||||
Outpatients | 7% | 48% | ||||
Inpatients | 13% | 52% |
- Revenues from sales of goods were Baht 941 million, increased by 18% YoY due mainly to an increase in sales of the A.N.B. Laboratories Co., Ltd. ("ANB") and Medicpharma Co., Ltd. ("MP").
- Other incomes were Baht 291 million, increased by 39% YoY mainly from reopening of Movenpick BDMS Wellness Resort Bangkok in Jan 2023 after temporary closed for renovation.
Operating Income Comparing to 1Q23 (QoQ)
The operating income in second quarter is normally low season of every year. However, this year, total operating income in 2Q23 was similar to 1Q23, given positive factors from good growth of 5% QoQ of Thai patient revenues while international patient revenues decreased 11% QoQ, which showed less decline than in the past.
Operating Expenses
(THB mm) | 2Q23 | 2Q22 | YoY | QoQ |
Cost of hospital | ||||
operations and others | 15,432 | 14,147 | 9% | 2% |
Administrative expenses | 4,876 | 4,200 | 16% | 5% |
Total Operating | ||||
Expenses (Including | ||||
depreciation) | 20,308 | 18,347 | 11% | 3% |
2
Total Operating Expenses Comparing to 2Q22 (YoY)
In 2Q23, the Company and its subsidiaries reported total operating expenses & depreciation of Baht 20,308 million, an increase of Baht 1,961 million or 11% YoY. The total operating expenses & depreciation increased mainly from higher doctor fees given the growth in revenue from hospital operations and higher clinical & non-clinical staff expenses together with an increase in marketing, utility and other administration expenses.
Other Major Items
- Finance expenses decreased to Baht 134 million in 2Q23 or decreased by 11% YoY from debentures redemption.
- Corporate income tax in 2Q23 were Baht 812 million, increased by 17% YoY due mainly to increase in pre-tax profit.
Profitability Analysis
(THB mm) | 2Q23 | 2Q22 | %Chg |
EBITDA | 5,510 | 5,120 | 8% |
EBITDA margin | 22.6% | 23.3% | |
EBIT | 4,130 | 3,665 | 13% |
EBIT margin | 16.9% | 16.7% | |
Net profit | 3,063 | 2,664 | 15% |
Net profit margin | 12.6% | 12.1% | |
EPS (THB) | 0.19 | 0.17 | 15% |
Weighted average number | |||
of ordinary shares | |||
(mm shares) | 15,892 | 15,892 | |
= Total operating income - Total operating expenses (Excluding depreciation and amortization)
Profitability margin calculated based on operating income
The Company and its subsidiaries recorded 2Q23 EBITDA of Baht 5,510 million, increased by 8% from 2Q22 but EBITDA margin decreased from 23.3% in 2Q22 to 22.6% in 2Q23 due to lower occupancy rate
3
and economies of scales from a decline in number of COVID-19 patients. Noted that COVID-19 revenues in 2Q22 was high at 13% of revenues from hospital operations.
Net profit of Baht 3,063 million, increased by 15% YoY due to recovery of Thai and international patients together with lower depreciation and positive impact from additional stake in Samitivej Public Company Limited ("SVH") resulting in decrease in non-controlling interests in subsidiaries.
6M23 Consolidated Financial Summary
Operating Income
(THB mm) | 6M23 | 6M22 | %Chg |
Revenues from hospital | |||
operations | 46,225 | 43,141 | 7% |
Revenue from sales of goods | 1,866 | 1,617 | 15% |
Other income | 594 | 382 | 56% |
Total Operating Income | 48,685 | 45,140 | 8% |
In 6M23, total operating income were Baht 48,685 million, an increase of Baht 3,545 million or increased by 8% YoY, primarily due to
- Revenues from hospital operations were Baht 46,225 million, an increase of Baht 3,084 million or increased by 7% YoY mainly from higher intensity at COE. In addition, an increase was also mainly from increase in international patient revenues of 30% YoY, driven by an increase of CLMV patients 58% YoY, Middle East patients 57% YoY, and Chinese patients 53% YoY. Thai patient revenues were flat YoY due to an impact from a decline in COVID-19 patient revenues (contributed 15% of hospital revenues in 6M22). If excluding COVID-19 revenue, Thai-non COVID- 19 revenues would increase 25% YoY. Consequently, revenue proportion between Thai and international patients changed from 77%:23% in 6M22 to 72%:28% in 6M23.
Both hospital in Bangkok & vicinity and hospital outside Bangkok & vicinity increased 4% and 11% YoY, respectively.
The occupancy rate decreased from 75% in 6M22 to 65% in 6M23 due to sharp decline in admission of COVID-19 patients.
Revenues from hospital | Chg. | % of | |
operations in 6M23 | (YoY) | r | evenues |
Revenues growth from | |||
hospital operations | 7% | ||
Breakdown by nationality | |||
Thai | 0% | 72% | |
Thai-Non COVID | 25% | ||
International | 30% | 28% | |
Breakdown by location | |||
Bangkok & Vicinity | 4% | 56% | |
Outside Bangkok | 11% | 44% | |
Breakdown by type of patients | |||
Outpatients | 10% | 48% | |
Inpatients | 5% | 52% |
- Revenues from sales of goods were Baht 1,866 million, increased by 15% YoY due to increase in sales of the A.N.B. and MP.
- Other income was Baht 594 million, increased by 56% YoY due to reopening of Movenpick BDMS Wellness Resort Bangkok in Jan 2023 after temporary closed for renovation.
Operating Expenses
(THB mm) | 6M23 | 6M22 | %Chg |
Cost of hospital operations | |||
and others | 30,554 | 28,598 | 7% |
Administrative expenses | 9,509 | 8,225 | 16% |
Total Operating Expenses | |||
(Including depreciation) | 40,063 | 36,823 | 9% |
In 6M23, the Company and its subsidiaries reported total operating expenses & depreciation of Baht 40,063 million, increase of Baht 3,240 million or 9% YoY mainly from higher doctor fees, clinical & non- clinical staff expenses together with an increase in
marketing, utility and other administration expenses.
Other Major Items
- Finance expenses decreased to Baht 298 million in 6M23 or decreased by 4% YoY from debentures redemption.
- Corporate income tax in 6M23 were Baht 1,692 million, increased by 6% YoY due mainly to increase in pre-tax profit in 6M23.
Profitability Analysis
(THB mm) | 6M23 | 6M22 | %Chg |
EBITDA | 11,497 | 11,293 | 2% |
EBITDA margin | 23.6% | 25.0% | |
EBIT | 8,760 | 8,370 | 5% |
EBIT margin | 18.0% | 18.5% | |
Net profit | 6,533 | 6,107 | 7% |
Net profit margin | 13.4% | 13.5% | |
EPS (THB) | 0.41 | 0.38 | 7% |
Weighted average | |||
number of ordinary | |||
shares (mm shares) | 15,892 | 15,892 | |
= Total operating income - Total operating expenses (Excluding depreciation and amortization)
Profitability margin calculated based on operating income
The Company and its subsidiaries recorded EBITDA of Baht 11,497 million in 6M23, increased by 2% YoY. However, EBITDA margin decreased from 25.0% in 6M22 to 23.6% in 6M23.
Net profit in 6M23 was Baht 6,533 million, increased by 7% YoY with net profit margin of 13.4%, similar to 6M22. EPS was Baht 0.41 per share in 6M23.
4
Assets
(THB mm) | Jun 23 | Dec 22 | %Chg |
Cash & cash equivalents | 10,442 | 12,668 | (18)% |
Trade & other | |||
receivables | 10,091 | 10,484 | (4)% |
Inventories | 2,049 | 2,211 | (7)% |
Property, premises & | |||
equipment | 82,695 | 81,860 | 1% |
Goodwill | 17,539 | 17,539 | 0% |
Right-of-use assets | 9,635 | 9,668 | (0)% |
Other assets | 6,211 | 7,112 | (13)% |
Total assets | 138,662 | 141,543 | (2)% |
As of 30 June 2023, the Company and its subsidiaries reported total assets of Baht 138,662 million, decreased by 2% from 31 December 2022 due mainly to decrease in cash & cash equivalents Baht 2,226 million.
The Company carried goodwill of Baht 17,539 million, which remain unchanged from 31 December 2022. Goodwill were mainly from acquisitions. Such goodwill is tested for impairment annually and when circumstances indicate that the carrying value may be impaired. However, the Company has considered that this goodwill is not impaired.
Other assets of Baht 6,211 million mainly consisted of (1) intangible assets which mainly were computer software of Baht 1,703 million (2) other current financial assets which were investment in fixed deposits and mutual funds of Baht 1,038 million, and (3) other non-current financial assets which were investment in equity and debt instruments of Baht 1,134 million.
Liabilities and Equity
(THB mm) | Jun 23 | Dec 22 | %Chg |
Short-term loans from | |||
financial institutions | - | 500 | (100)% |
Trade & Other payables | 5,519 | 6,176 | (11)% |
Accrued expenses | 7,374 | 5,426 | 36% |
Debentures * | 6,498 | 11,498 | (43)% |
Long-term loans * | 4,000 | 4,000 | 0% |
Liabilities under lease | |||
agreements * | 7,681 | 7,564 | 2% |
Other liabilities | 12,538 | 12,667 | (1)% |
Total liabilities | 43,610 | 47,830 | (9)% |
Equity attributable to equity | |||
holder of the Company | 91,783 | 89,879 | 2% |
Non-controlling interests | 3,268 | 3,834 | (15)% |
Total equity | 95,051 | 93,713 | 1% |
* Including current portion |
Total consolidated liabilities as of 30 June 2023 were Baht 43,610 million, decreased by 9% from 31 December 2022 due mainly to a decrease in debentures of Baht 5,000 million.
Total consolidated shareholders' equity as of 30 June 2023 was Baht 95,051 million, slightly increased by 1% from 31 December 2022.
Liquidity and Capital Management
Cash Flow
(THB mm) | 6M23 |
Net cash from operating activities | 11,481 |
Net cash used in investing activities | (2,365) |
Net cash used in financing activities | (11,341) |
Net decrease in cash and cash equivalents | (2,226) |
Beginning cash and cash equivalents | 12,668 |
Ending cash and cash equivalents | 10,442 |
For the six-month period ended 30 June 2023, the Company and its subsidiaries had net decrease in cash and cash equivalent of Baht 2,226 million from the beginning balance of Baht 12,668 million. As a
5
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Bangkok Dusit Medical Services pcl published this content on 11 August 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 August 2023 13:13:24 UTC.